Filter your results
- 2
- 1
- 3
- 3
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemiaNature, 2010, 467 (7313), pp.318-322. ⟨10.1038/nature09328⟩
Journal articles
cea-00905288v1
|
||
|
Gene Therapy in a Patient with Sickle Cell DiseaseNew England Journal of Medicine, 2017, 376 (9), pp.848 - 855. ⟨10.1056/NEJMoa1609677⟩
Journal articles
inserm-01834781v1
|
||
|
Hematopoietic stem cell Gene therapy with a lentiviral vector in X-linked adrenoleukodystrophyScience, 2009, 326 (5954), pp.818-823. ⟨10.1126/science.1171242⟩
Journal articles
cea-00817492v1
|